Generated by GPT-5-mini| Instituto Nacional de Infectologia Evandro Chagas | |
|---|---|
| Name | Instituto Nacional de Infectologia Evandro Chagas |
| Native name | Instituto Nacional de Infectologia Evandro Chagas |
| Established | 1980s |
| Type | Research institute and hospital |
| City | Rio de Janeiro |
| Country | Brazil |
| Parent | Fundação Oswaldo Cruz |
Instituto Nacional de Infectologia Evandro Chagas is a Brazilian biomedical research and clinical institution specializing in infectious diseases, affiliated with Fundação Oswaldo Cruz, located in Rio de Janeiro. The institute integrates clinical care, laboratory research, and public health response for pathogens linked to outbreaks such as Dengue fever, Zika virus, and Yellow fever. It operates within national networks including the Ministry of Health (Brazil) and international frameworks involving World Health Organization and Pan American Health Organization initiatives.
The institute traces origins to postwar public health reforms associated with Oswaldo Cruz and the expansion of Fundação Oswaldo Cruz during the late 20th century, reflecting responses to epidemics like Yellow fever and urban Dengue fever resurgence. During the 1980s and 1990s it formalized specialized services in parallel with national programs under the Ministry of Health (Brazil), while collaborating with research centers such as Instituto Oswaldo Cruz and Fiocruz branches. In the 21st century the institute became a focal point during the Zika virus epidemic and the COVID-19 pandemic, aligning with emergency operations coordinated by Secretaria de Vigilância em Saúde and international partners including Centers for Disease Control and Prevention and European Centre for Disease Prevention and Control.
Administratively the institute functions as a component of Fundação Oswaldo Cruz governance structures and reports through designated directorates that mirror models used by institutes like Instituto Evandro Chagas and Instituto Adolfo Lutz. Its executive leadership typically includes a director, scientific committee, and clinical chiefs who liaise with entities such as the National Health Surveillance Agency (ANVISA) and the Brazilian Ministry of Science and Technology. Internal departments coordinate with external labs including Fiocruz Ceará and public hospitals such as Hospital Federal dos Servidores do Estado to manage patient referral, research ethics, and biosafety oversight consistent with guidelines from Comissão Nacional de Ética em Pesquisa.
The institute conducts translational research spanning virology, bacteriology, parasitology, and immunology, interfacing with laboratories like Laboratório Central de Saúde Pública and collaborating on molecular surveillance initiatives with Instituto Adolfo Lutz and Oswaldo Cruz Foundation affiliates. Clinical services include inpatient and outpatient care for conditions such as Leptospirosis, Chikungunya, and severe arboviral disease, modeled after specialty centers at Hospital Universitário Clementino Fraga Filho and supported by diagnostic platforms similar to those used at Instituto Oswaldo Cruz. Research outputs inform policies adopted by Ministério da Saúde (Brazil) and are disseminated through partnerships with journals and bodies like Revista da Sociedade Brasileira de Medicina Tropical and the Pan American Health Organization.
The institute played active roles in response to the Zika virus epidemic in the Americas and the 2015–2016 Zika outbreak, contributing clinical characterization of congenital infection and coordinating with obstetric referral networks including Hospital Geral de Nova Iguaçu and surveillance teams from Secretaria Municipal de Saúde do Rio de Janeiro. During the Yellow fever outbreak in Brazil (2016–2018), it supported vaccination campaigns and laboratory confirmation alongside Instituto Evandro Chagas. In the COVID-19 pandemic in Brazil, the institute participated in case management, genomic surveillance tied to efforts by Rede Genômica Fiocruz, and trials in coordination with national research consortia and international collaborators such as World Health Organization initiatives.
Located in Rio de Janeiro (city), the institute's campus includes biosafety level laboratories comparable to those at Instituto Oswaldo Cruz and clinical wards similar to tertiary referral centers like Hospital Federal do Andaraí. On-site facilities host molecular diagnostics, serology units, and vector research spaces used for entomological studies linked to Aedes aegypti surveillance programs run with municipal secretariats and university partners such as the Federal University of Rio de Janeiro and Universidade do Estado do Rio de Janeiro.
The institute offers graduate and postgraduate training in collaboration with universities, following frameworks seen at Fundação Oswaldo Cruz graduate programs and coordinating residencies modeled after those at Hospital Universitário Pedro Ernesto. Training includes clinical fellowships in infectious diseases, laboratory internships in virology and bacteriology, and public health courses developed with agencies like Fundação Oswaldo Cruz education units and linked to international exchanges with Centers for Disease Control and Prevention and London School of Hygiene & Tropical Medicine.
Collaborative networks extend to national and international organizations including Fundação Oswaldo Cruz, Ministry of Health (Brazil), Pan American Health Organization, World Health Organization, Centers for Disease Control and Prevention, and academic partners such as Federal University of Rio de Janeiro and Universidade Estadual do Norte Fluminense. Research consortia and surveillance projects connect the institute with laboratories like Instituto Evandro Chagas, Instituto Adolfo Lutz, and global initiatives including Global Outbreak Alert and Response Network, enabling joint studies, sample sharing, and multi-center clinical trials.
Category:Medical research institutes in Brazil Category:Organizations based in Rio de Janeiro (city)